[The status of imaging methods for the treatment of patients with Parkinson's syndrome]

Dtsch Med Wochenschr. 2008 May;133 Suppl 1:S8-10. doi: 10.1055/s-2008-1075679.
[Article in German]

Abstract

The accuracy of the diagnosis of Parkinson's disease early in the course of the disease remains a clinical challenge. Imaging of dopamine transporters with DatSCAN and SPEC tomography contributes to identifying patients without nigral degeneration and thus helps preventing unnecessary and potentially harmful treatments. The cost of these imaging procedures needs to be set against the cost of unnecessary medication.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Cost-Benefit Analysis
  • Dopamine Agents / economics
  • Dopamine Agents / therapeutic use
  • Dopamine Plasma Membrane Transport Proteins / analysis
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Humans
  • Parkinson Disease / diagnosis*
  • Parkinson Disease / physiopathology
  • Parkinson Disease / therapy*
  • Positron-Emission Tomography* / economics
  • Sensitivity and Specificity
  • Substantia Nigra / pathology
  • Tomography, Emission-Computed, Single-Photon* / economics

Substances

  • Dopamine Agents
  • Dopamine Plasma Membrane Transport Proteins